VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NHI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NHINational Health Investors, Inc.
$77.55$3.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNHICash Flow

National Health Investors, Inc. (NHI) Cash Flow Statement

30Y historyFree accessUpdated daily

FFO reached $64.5 million in 2026Q1, maintaining a stable dividend payout ratio of 0.69 relative to AFFO despite rising maintenance capital expenditures of $2.9 million.

NHI Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations246.77M240.23M208.17M184.45M185.34M210.86M232.15M240.96M207.87M197.32M177.22M164.43M126.14M104.19M86.27M76.85M77.54M69.21M67.13M66.53M57.8M59.01M57.09M68.03M66.09M59.76M63.61M73.43M84.93M89.94M76.71M
Operating CF Growth %63.82%15.4%12.86%-0.48%-12.1%-9.17%-3.65%15.92%5.34%11.35%7.78%30.35%21.07%20.78%12.25%-0.89%12.04%3.1%0.91%15.09%-2.04%3.36%-16.08%2.94%10.59%-6.05%-13.38%-13.54%-5.57%17.24%38.97%
Operating CF / Revenue %61.25%63.46%62.11%57.67%66.62%70.59%69.75%75.75%70.56%70.81%71.32%71.81%71.06%88.43%88.98%92.93%98.91%107.77%106.55%106.77%38.35%37.49%36.7%41.87%38.47%42.94%43.12%55.99%83.03%81.63%77.15%
Net Income148.11M142.18M137.99M134.38M65.5M111.97M185.31M160.45M154.33M159.37M152.72M150.31M103.05M107.18M90.9M81.13M69.42M64.23M57.51M96.44M69.23M54.41M56.38M43.81M30.79M-63K33.72M53.62M69.64M75.39M67.16M
Depreciation & Amortization88.38M83.84M74.34M69.97M70.88M80.8M83.15M76.82M75.79M72.96M63.13M56.63M40.69M20.91M16.98M11.99M11.2M8.62M7.94M11.72M11.81M12.6M14.45M15.38M16.38M14.66M14.17M11.48M8.96M8.04M6.83M
Stock-Based Compensation0004.61M8.61M8.41M3.06M3.65M2.49M2.61M1.73M2.13M2.02M2.34M2.17M3.09M2.37M853K7K000000000000
Other Non-Cash Items4.07M6.95M-1.6M-27.8M43.04M39.16M-32.64M-19.48M-30.02M-27.28M-23.91M-25.03M-16.46M-9.82M-8.27M-3.88M-3.87M-157K388K-38.3M-14.11M-2.83M-9.14M5.26M12.71M29.34M6.64M19.73M-1.71M-1.46M-6.81M
Working Capital Changes6.29M7.26M-2.56M3.29M-2.7M-438K-6.74M18.7M-571K-2.46M2.4M3.75M-3.72M3.77M-1.28M-1.15M417K-2.04M-2.78M-3.33M-9.12M-5.17M-4.6M3.58M6.21M15.82M9.08M-11.4M8.04M7.97M9.53M
Cash from Investing-299.07M-271.07M-191.55M-11.63M197.94M185.28M-89.71M-342.52M-250.29M-163.85M-329.84M-136.33M-540.32M-625.82M-99.81M-55.47M-92.03M-55.28M52.17M21.43M47.17M333K65.74M64.72M23.23M41.86M29.18M-53.37M-78.74M49.18M-115.92M
Acquisitions (Net)1.75M1.75M1.17M011.74M-187.54M-875K643K00-17M114.52M00-8.31M06.25M00-14M24.21M14.45M4.39M00000000
Purchase of Investments-363.1M-345.18M-202.61M0-86.17M-119.12M0-327.42M-238.75M-217.76M-483.41M-8.46M0000-12.42M-4.78M0-361.46M-11.06M-22.08M-1.02M00-23.74M-41.46M-55.34M-135.78M-115.88M-153.08M
Sale of Investments82.97M92.33M25.63M0288.17M306.65M02.9M4.35M18.18M59.61M57.41M00125K12.86M9.56M30.89M56.18M347.25M16.85M14.8M10.82M405K6.28M17.92M13.12M0000
Other Investing000-7.89M-11.17M185.34M-88.68M-643K-102.64M-6.68M-22.43M-185.27M-4.54M7.89M-91.63M7.47M3.33M175K42K52.13M19.66M5.42M53.23M74.33M33.52M49.62M60.73M16.29M97.76M188.91M105.06M
Cash from Financing-60.03M23.96M-14.74M-169.72M-401.25M-402.99M-111.76M107.32M44.26M-35.05M144.16M-18.1M406.15M523.77M6.83M-8.16M-28.57M-68.46M-94.42M-171.42M-59.68M-88.09M-55.31M-82.13M-59.86M-135.27M-62.27M-23.75M-50.7M-77.6M40.48M
Dividends Paid-173.02M-169.7M-156.51M-156.24M-161.77M-182.9M-194.58M-179.74M-165.39M-153.04M-138.3M-124.66M-100.65M-85.14M-78.92M-67.89M-66.52M-64.55M-85.52M-67.44M-52.55M-53.26M-48.65M-43M-41.1M-1.88M-51.06M-73.76M-75.76M-73.58M-64.48M
Common Dividends-128.58M-169.7M-156.51M-156.24M-161.77M-182.9M-194.58M-179.74M-165.39M-153.04M-138.3M-124.66M-100.65M-85.14M-78.92M-67.89M-66.52M-64.55M-85.52M-67.44M-52.55M-53.26M-48.65M-43M-41.1M-1.88M-51.06M-73.76M-75.76M-73.58M-64.48M
Debt Issuance (Net)01000K1000K-1000K-1000K-1000K1000K1000K1000K-1000K1000K1000K1000K1000K1000K00-1000K-1000K-1000K-1000K-1000K-1000K337K-1000K-1000K-1000K1000K1000K-1000K1000K
Share Repurchases0000-151.95M0000000000000-3.62M0-3.53M0-578K00-7.77M-3M0-33.25M00
Other Financing-6.49M-2.14M-7.9M-1.05M5.86M-68.45M-6.1M-1.06M-141.01M57.49M104.05M-344.9M467.31M96.03M-179K59.73M37.95M78K245K0000-39.92M0020M-30.3M-56.59M-27K-284.93M
Net Change in Cash-110.06M-4.67M1.94M3.1M-17.97M-6.86M30.67M5.76M1.84M-1.57M-8.45M10M-8.03M2.14M-6.71M13.22M-43.05M-54.52M24.89M-83.46M45.3M-28.75M67.53M50.63M29.46M-33.65M30.53M-3.68M-44.51M61.52M1.28M
Exchange Rate Effect2.27M2.21M57K0000000000000000000000000000
Cash at Beginning19.62M24.29M22.35M21.52M39.48M46.34M15.67M9.91M8.07M4.64M13.29M3.29M11.31M9.17M15.89M2.66M45.72M100.24M75.36M158.81M132.47M161.22M93.69M43.06M13.6M47.25M16.72M20.41M64.92M3.4M2.12M
Cash at End24.95M19.62M24.29M24.62M21.52M39.48M46.34M15.67M9.91M3.06M4.83M13.29M3.29M11.31M9.17M15.89M2.66M45.72M100.24M75.36M177.76M132.47M161.22M93.69M43.06M13.6M47.25M16.72M20.41M64.92M3.4M
Free Cash Flow226.1M220.26M192.44M180.71M180.71M210.79M231.99M222.96M60.22M21.98M-189.79M49.91M-409.63M-529.52M86.27M1.05M-21.19M-12.36M63.09M64.04M55.31M46.75M55.41M58.02M49.52M57.82M60.41M59.12M44.2M66.09M8.82M
FCF Growth %13.93%14.46%6.49%-0%-14.27%-9.14%4.05%270.21%173.97%111.58%-480.31%112.18%22.64%-713.83%8131.49%104.95%-71.5%-119.59%-1.49%15.79%18.31%-15.64%-4.5%17.17%-14.36%-4.28%2.19%33.73%-33.11%649.21%-80%
FCF / Revenue %56.12%58.19%57.41%56.5%64.96%70.57%69.71%70.09%20.44%7.89%-76.38%21.79%-230.76%-449.41%88.98%1.27%-27.03%-19.24%100.13%102.77%36.69%29.7%35.62%35.71%28.83%41.55%40.95%45.07%43.21%59.98%8.87%

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

SHOP transition operational volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Dividend Coverage Remains Comfortably Supported

According to the reported quarterly data, NHI maintained a consistent dividend payout ratio relative to AFFO, with the 2026Q1 ratio of 0.69 indicating that the company retains a significant buffer to support its distribution despite the ongoing strategic transition toward more operationally intensive SHOP assets.

The stability of the dividend coverage ratio suggests that management is successfully balancing capital allocation between shareholder returns and the funding of property-level improvements. Investors should monitor whether this payout ratio trends upward as the SHOP portfolio matures, as any sustained increase could signal a tightening of the cash flow cushion.

FFO Reconciliation Highlights Depreciation Impact

As evidenced by the consistent spread between Net Income and FFO, with FFO reaching $64.5 million in 2026Q1 compared to $40.1 million in Net Income, the company's earnings are heavily influenced by non-cash depreciation charges inherent in its healthcare real estate portfolio.

The persistent gap between GAAP earnings and FFO underscores the necessity of focusing on cash-based metrics to evaluate true performance. This distortion appears to be a structural feature of the business model rather than a sign of accounting volatility, though it warrants ongoing scrutiny as the asset mix shifts.

Rising Maintenance Capex Reflects Complexity

Based on the financial statements, maintenance capital expenditures reached $2.9 million in 2026Q1, reflecting a moderate increase in the capital intensity required to support the portfolio as the company integrates more SHOP assets that demand higher levels of recurring tenant improvements and facility maintenance.

The uptick in capital expenditures suggests that the transition to an operating model is beginning to impact the cash flow statement more directly than the previous NNN-heavy structure. Analysts should investigate whether these costs are stabilizing or if they represent a permanent increase in the required reinvestment rate for the portfolio.

FFO Quality Remains Structurally Sound

Analysis of the cash flow statements indicates that FFO consistently tracks above GAAP operating cash flow, with the 2026Q1 FFO of $64.5 million exceeding the $53.4 million in operating cash flow, suggesting that the company's earnings quality is supported by stable, non-cash adjustments.

The relationship between FFO and operating cash flow appears to be well-aligned with historical norms for the sector. This suggests that the company is not currently relying on aggressive working capital management to inflate its reported cash earnings, which provides a degree of confidence in the sustainability of current cash flows.

NHI — Frequently Asked Questions

Quick answers to the most common questions about buying NHI stock.

How much cash does National Health Investors, Inc. (NHI) generate from operations?

National Health Investors, Inc. (NHI) generated $240.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is National Health Investors, Inc.'s free cash flow?

National Health Investors, Inc. (NHI) generated $220.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is National Health Investors, Inc.'s capital expenditure (CapEx)?

National Health Investors, Inc. (NHI) spent $20.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does National Health Investors, Inc. distribute cash to shareholders?

In 2025, National Health Investors, Inc. (NHI) returned $169.7M to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.